Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT04814667
Eligibility Criteria:
Inclusion Criteria:
* Adult male or female patients
* Histological confirmed diagnosis of advanced/metastatic solid tumor type.
* Patients previously, currently or to be treated with Larotrectinib within the ATU/post-ATU period. Patient must be \> 25 years-old at time of larotrectinib start.
* Patients not opposed to collection of personal clinical data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Study:
NCT04814667
Study Brief:
Protocol Section:
NCT04814667